肿瘤特异增殖病毒的研究进展
摘要
经转录调节修饰的肿瘤特异增殖病毒可特异性地杀伤肿瘤细胞 ,具有临床治疗肿瘤的潜在价值 ,是近年来肿瘤研究的热点之一 ,并取得了很大的进展 。
出处
《国外医学(肿瘤学分册)》
2004年第3期189-192,共4页
Foreign Medical Sciences (Cancer Section)
参考文献26
-
1Kurihara T, Brouth DE, Kovesdi I, et al. Selectivity of a replication-competent adenovirus for human breas carcinoma cells expressing the MUC-antigen. J Clini Invest, 2000, 106(6) : 763-771.
-
2Steele TA. Recent development in the virus therapy of cancer.Proc Soc Exp Biol Med, 2000, 223(2) : 118-127.
-
3Demers GW, Johnson DE, Tsai V, et al. Pharmacologic indicators of antitumor efficacy for oncolytic virotherapy. Cancer Res, 2003,63(14) :4003-4008.
-
4Biederer C, Ries S, Brandts CH, et al. Replication-selective vires to cancer therapy. J Mol Med, 2002, 80(3) : 163-175.
-
5Johnson L, Shen A, Boyle L, et al. Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents. Cancer Cell, 2002, 1(4) :325-337.
-
6Freytag SO, Rogulski KR, Paielli DL, et al. A novel three-pronged approach to kill cancer cells selectively, concomitant vrial, double suicide gene, and radiotherapy. Hum Gene Ther, 1998, 9 ( 9 ) :1323-1333.
-
7Heise C, Hermiston T, Johnson L, et al. An adenovirus E1A mutant than demonstrates potend and selective systenlic anti-tumoral efficacy. Nat Med, 2000, 6(10):1134-1139.
-
8Li Y, Yu DC, Chen Y, et al. A hepatocellular carcinoma-specific adenovirus vaiant, CV 890, eliminates distant human liver tumors in combination with doxorubicin. Cancer Res, 2001, 61( 17):6428-6436.
-
9Hallenbeck PL, Chang YN, Hay C, et al. A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellar carcinoma. Hum Gene Ther, 1999, 10(10) : 1721-1733.
-
10Takahashi M, Sato T, Sagawa T, et al. E1B-55k-deleted adenovirus expressing E1A-13s by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor. Mol Ther, 2002, 5(5 Pt 1 ):627-634.
-
1任如龙,马俐.日本对肿瘤标记物NSE的临床应用现状[J].日本医学介绍,1991,12(10):476-477.
-
2杨玉波,张强,潘克勤.门静脉5—Fu化疗预防大肠癌肝转移的临床应用现状[J].实用肿瘤学杂志,2000,14(2):157-159. 被引量:3
-
3赵燕,张茹.厄洛替尼治疗非小细胞肺癌的机制、现状与展望[J].中国药物警戒,2010,7(10):617-619. 被引量:3
-
4立彦,夏伟,瞿卫,王自正.生长抑素及其受体的研究与临床应用现状[J].国外医学(临床生物化学与检验学分册),2004,25(6):529-531. 被引量:6
-
5李秀琴,张淑兰.宫颈癌新辅助化疗的临床应用现状[J].中国妇产科临床杂志,2010,11(5):395-396. 被引量:15
-
6陈哲,毛俊年,刘伟.原发性肝癌外放疗临床应用现状[J].世界最新医学信息文摘,2016,16(30):70-71. 被引量:1
-
7田永刚,许军,关英辉.腹腔镜技术在结、直肠癌手术中的临床应用现状[J].腹腔镜外科杂志,2006,11(3):266-268. 被引量:1
-
8唐玉琦,郑玲.复方苦参注射液的抗肿瘤临床应用现状[J].肿瘤药学,2015,5(2):92-96. 被引量:12
-
9连海英,张雪林.磁共振灌注成像在肝硬化的临床应用[J].国外医学(临床放射学分册),2006,29(1):36-39. 被引量:9
-
10庞东生,宋志刚,许杨,程小飞,王肇炎.高压氧在肿瘤化疗中的实验研究及临床应用现状[J].中华全科医学,2010,8(7):907-909. 被引量:4